Cullen/Frost Bankers, Inc.
BankPosition in COLL — Collegium Pharmaceutical, Inc
CIK 39263
San Antonio, TX
Position in COLL
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$43,548
+$31,577 QoQ
Shares Held
1,203
+232.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#220
of 277 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in COLL Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Cullen/Frost Bankers, Inc. holds $1,827,426 across 9 Drug Manufacturers - Specialty & Generic names. COLL ranks #5 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
21,790 | $1,565,829 | |
| 2 | HLN |
Haleon plc
|
5,885 | $54,907 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
83 | $44,971 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
260 | $43,820 | |
| 5 | COLL |
Collegium Pharmaceutical, Inc
This page
|
1,203 | $43,548 | |
| 6 | PAHC |
Phibro Animal Health Corp
|
1,002 | $31,462 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
607 | $24,905 | |
| 8 | VTRS |
Viatris Inc
|
968 | $15,371 |
All Filings in COLL
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $43,548 | 1,203 | Shares | Defined | 2026-07-27 | |
| 2026-03-31 | $11,971 | 362 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $14,908 | 322 | Shares | Defined | 2026-02-06 | |
| No filing history on record for this holder in this stock. | ||||||